Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The potential use of cell-free-circulating-tumor DNA as a biomarker for prostate cancer

2 Jun 2016

Abstract excerpt

INTRODUCTION: We are yet to identify an accurate, precise and non-invasive biomarker for the detection of prostate cancer. It would undoubtedly be useful to have a reliable and cost-effective biomarker to inform clinical practice, in order to make a non-invasive diagnosis and to predict risk of progression to aggressive prostate cancer. Since the detection of cell-free-circulating-tumor DNA in the body fluids of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27254598
DOI: 10.1080/14737159.2016.1197121

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The potential use of cell-free-circulating-tumor DNA as a biomarker for prostate cancerPMID 27254598Read ↗

Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate CancerSemantic proximity Read ↗

The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancerSemantic proximity Read ↗

Characterization of cell-free circulating DNA in plasma in patients with prostate cancerSemantic proximity Read ↗

Cell-free and circulating tumor cell-based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine?Semantic proximity Read ↗

Cell‐free DNA and RNA in Plasma as a New Molecular Marker for Prostate and Breast CancerSemantic proximity Read ↗

Post-Biopsy Cell-Free DNA From Blood: An Open Window on Primary Prostate Cancer Genetics and BiologySemantic proximity Read ↗

Post-biopsy cell-free DNA from blood: an open window on primary prostate cancer genetics and biologySemantic proximity Read ↗

Liquid biopsy with cell free DNA: new horizons for prostate cancer.Semantic proximity Read ↗

Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented testSemantic proximity Read ↗

Circulating Tumor DNA Biomarkers for Response Assessment in Prostate CancerSemantic proximity Read ↗

Integrative genomic and epigenomic profiling in plasma and urinary cell-free DNA improves early risk stratification of newly diagnosed prostate cancerSemantic proximity Read ↗

Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical PotentialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.